|
1
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: From genes to environment. Nat Rev Cancer.
6:674–687. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shariff MI, Cox IJ, Gomaa AI, Khan SA,
Gedroyc W and Taylor-Robinson SD: Hepatocellular carcinoma: Current
trends in worldwide epidemiology, risk factors, diagnosis and
therapeutics. Expert Rev Gastroenterol Hepatol. 3:353–367. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Trinchet JC, Alperovitch A, Bedossa P,
Degos F, Hainaut P and Beers BV: Epidemiology, prevention,
screening and diagnosis of hepatocellular carcinoma. Bull Cancer.
96:35–43. 2009.(In French). PubMed/NCBI
|
|
5
|
Poon D, Anderson BO, Chen LT, Tanaka K,
Lau WY, Van Cutsem E, Singh H, Chow WC, Ooi LL, Chow P, et al:
Asian Oncology Summit: Management of hepatocellular carcinoma in
Asia: Consensus statement from the Asian Oncology Summit 2009.
Lancet Oncol. 10:1111–1118. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yeh FS, Yu MC, Mo CC, Luo S, Tong MJ and
Henderson BE: Hepatitis B virus, aflatoxins, and hepatocellular
carcinoma in southern Guangxi, China. Cancer Res. 49:2506–2509.
1989.PubMed/NCBI
|
|
7
|
Long XD, Ma Y, Wei YP and Deng ZL: The
polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin
B1-related hepatocellular carcinoma in Guangxi population, China.
Hepatol Res. 36:48–55. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Imaizumi T, Higaki Y, Hara M, Sakamoto T,
Horita M, Mizuta T, Eguchi Y, Yasutake T, Ozaki I, Yamamoto K, et
al: Interaction between cytochrome P450 1A2 genetic polymorphism
and cigarette smoking on the risk of hepatocellular carcinoma in a
Japanese population. Carcinogenesis. 30:1729–1734. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nahon P, Sutton A, Rufat P, Ziol M, Thabut
G, Schischmanoff PO, Vidaud D, Charnaux N, Couvert P, Ganne-Carrie
N, et al: Liver iron, HFE gene mutations, and hepatocellular
carcinoma occurrence in patients with cirrhosis. Gastroenterology.
134:102–110. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Migita K, Miyazoe S, Maeda Y, Daikoku M,
Abiru S, Ueki T, Yano K, Nagaoka S, Matsumoto T, Nakao K, et al:
Cytokine gene polymorphisms in Japanese patients with hepatitis B
virus infection - association between TGF-beta1 polymorphisms and
hepatocellular carcinoma. J Hepatol. 42:505–510. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ognjanovic S, Yuan JM, Chaptman AK, Fan Y
and Yu MC: Genetic polymorphisms in the cytokine genes and risk of
hepatocellular carcinoma in low-risk non-Asians of USA.
Carcinogenesis. 30:758–762. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hirschhorn JN and Daly MJ: Genome-wide
association studies for common diseases and complex traits. Nat Rev
Genet. 6:95–108. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
De Bakker PI, Yelensky R, Pe'er I, Gabriel
SB, Daly MJ and Altshuler D: Efficiency and power in genetic
association studies. Nat Genet. 37:1217–1223. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Florez JC, Manning AK, Dupuis J, McAteer
J, Irenze K, Gianniny L, Mirel DB, Fox CS, Cupples LA and Meigs JB:
A 100K genome-wide association scan for diabetes and related traits
in the Framingham Heart Study: Replication and integration with
other genome-wide datasets. Diabetes. 56:3063–3074. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rothman N, Garcia-Closas M, Chatterjee N,
Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G,
Baris D, et al: A multi-stage genome-wide association study of
bladder cancer identifies multiple susceptibility loci. Nat Genet.
42(11): 978–84. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu C, Miao X, Huang L, Che X, Jiang G, Yu
D, Yang X, Cao G, Hu Z, Zhou Y, et al: Genome-wide association
study identifies five loci associated with susceptibility to
pancreatic cancer in Chinese populations. Nat Genet. 44:62–66.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, Hu
Z, Xu JH, Cai ZM, Huang W, Zhao GP, et al: Genome-wide association
study in a Chinese Han population identifies nine new
susceptibility loci for systemic lupus erythematosus. Nat Genet.
41:1234–1237. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kurbanov F, Tanaka Y and Mizokami M:
Geographical and genetic diversity of the human hepatitis B virus.
Hepatol Res. 40:14–30. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen CJ and Chen DS: Interaction of
hepatitis B virus, chemical carcinogen, and genetic susceptibility:
Multistage hepatocarcinogenesis with multifactorial etiology.
Hepatology. 36:1046–1049. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ming L, Thorgeirsson SS, Gail MH, Lu P,
Harris CC, Wang N, Shao Y, Wu Z, Liu G, Wang X, et al: Dominant
role of hepatitis B virus and cofactor role of aflatoxin in
hepatocarcinogenesis in Qidong, China. Hepatology. 36:1214–1220.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang H, Zhai Y, Hu Z, Wu C, Qian J, Jia
W, Ma F, Huang W, Yu L, Yue W, et al: Genome-wide association study
identifies 1p36.22 as a new susceptibility locus for hepatocellular
carcinoma in chronic hepatitis B virus carriers. Nat Genet.
42:755–758. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qu LS, Liu TT, Jin F, Guo YM, Chen TY, Ni
ZP and Shen XZ: Combined pre-S deletion and core promoter mutations
related to hepatocellular carcinoma: A nested case-control study in
China. Hepatol Res. 41:54–63. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qu L, Kuai X, Liu T, Chen T, Ni Z and Shen
X: Pre-S deletion and complex mutations of hepatitis B virus
related to young age hepatocellular carcinoma in Qidong, China.
PLoS One. 8:e595832013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qu LS, Liu JX, Liu TT, Shen XZ, Chen TY,
Ni ZP and Lu CH: Association of hepatitis B virus pre-S deletions
with the development of hepatocellular carcinoma in Qidong, China.
PLoS One. 9:e982572014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Llovet JM, Fuster J and Bruix J:
Barcelona-Clínic Liver Cancer Group: The Barcelona approach:
Diagnosis, staging, and treatment of hepatocellular carcinoma.
Liver Transpl. 10:S115–S120. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
World Medical Association Declaration of
Helsinki: Ethical principles for medical research involving human
subjects. JAMA. 284:3043–3045. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Al Olama AA, Kote-Jarai Z, Giles GG, Guy
M, Morrison J, Severi G, Leongamornlert DA, Tymrakiewicz M, Jhavar
S, Saunders E, et al: Multiple loci on 8q24 associated with
prostate cancer susceptibility. Nat Genet. 41:1058–1060. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kiemeney LA, Thorlacius S, Sulem P, Geller
F, Aben KK, Stacey SN, Gudmundsson J, Jakobsdottir M, Bergthorsson
JT, Sigurdsson A, et al: Sequence variant on 8q24 confers
susceptibility to urinary bladder cancer. Nat Genet. 40:1307–1312.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fletcher O, Johnson N, Gibson L, Coupland
B, Fraser A, Leonard A, dos Santos Silva I, Ashworth A, Houlston R
and Peto J: Association of genetic variants at 8q24 with breast
cancer risk. Cancer Epidemiol Biomarkers Prev. 17:702–705. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Beebe-Dimmer JL, Levin AM, Ray AM, Zuhlke
KA, Machiela MJ, Halstead-Nussloch BA, Johnson GR, Cooney KA and
Douglas JA: Chromosome 8q24 markers: Risk of early-onset and
familial prostate cancer. Int J Cancer. 122:2876–2879. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheng I, Plummer SJ, Jorgenson E, Liu X,
Rybicki BA, Casey G and Witte JS: 8q24 and prostate cancer:
Association with advanced disease and meta-analysis. Eur J Hum
Genet. 16:496–505. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yeager M, Orr N, Hayes RB, Jacobs KB,
Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee
N, et al: Genome-wide association study of prostate cancer
identifies a second risk locus at 8q24. Nat Genet. 39:645–649.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen CF, Hsu EC, Lin KT, Tu PH, Chang HW,
Lin CH, Chen YJ, Gu DL, Lin CH, Wu JY, et al: Overlapping
high-resolution copy number alterations in cancer genomes
identified putative cancer genes in hepatocellular carcinoma.
Hepatology. 52:1690–1701. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jia D, Wei L, Guo W, Zha R, Bao M, Chen Z,
Zhao Y, Ge C, Zhao F, Chen T, et al: Genome-wide copy number
analyses identified novel cancer genes in hepatocellular carcinoma.
Hepatology. 54:1227–1236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wacholder S, Chanock S, Garcia-Closas M,
El Ghormli L and Rothman N: Assessing the probability that a
positive report is false: An approach for molecular epidemiology
studies. J Natl Cancer Inst. 96:434–442. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Blakely TA, Bates MN, Baker MG and Tobias
M: Hepatitis B carriage explains the excess rate of hepatocellular
carcinoma for Maori, Pacific Island and Asian people compared to
Europeans in New Zealand. Int J Epidemiol. 28:204–210. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Katoh M: Networking of WNT, FGF, Notch,
BMP, and Hedgehog signaling pathways during carcinogenesis. Stem
Cell Rev. 3:30–38. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Purcell S, Neale B, Todd-Brown K, Thomas
L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ,
et al: PLINK: A tool set for whole-genome association and
population-based linkage analyses. Am J Hum Genet. 81:559–575.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
de Tayrac M, Etcheverry A, Aubry M,
Saïkali S, Hamlat A, Quillien V, Le Treut A, Galibert MD and Mosser
J: Integrative genome-wide analysis reveals a robust genomic
glioblastoma signature associated with copy number driving changes
in gene expression. Genes Chromosomes Cancer. 48:55–68. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mamori S and Tajiri H: Ets-1 is increased
in anticancer drug-containing media and hypoxic cultures, similar
to TACE. Scand J Gastroenterol. 44:507–508. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Varis A, Wolf M, Monni O, Vakkari ML,
Kokkola A, Moskaluk C, Frierson H Jr, Powell SM, Knuutila S,
Kallioniemi A, et al: Targets of gene amplification and
overexpression at 17q in gastric cancer. Cancer Res. 62:2625–2629.
2002.PubMed/NCBI
|
|
42
|
Liu J, Ghanim M, Xue L, Brown CD, Iossifov
I, Angeletti C, Hua S, Nègre N, Ludwig M, Stricker T, et al:
Analysis of Drosophila segmentation network identifies a JNK
pathway factor overexpressed in kidney cancer. Science.
323:1218–1222. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xing Y, Shi S, Le L, Lee CA, Silver-Morse
L and Li WX: Evidence for transgenerational transmission of
epigenetic tumor susceptibility in Drosophila. PLoS Genet.
3:1598–1606. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hahn SA, Schutte M, Hoque AT, Moskaluk CA,
da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban
RH, et al: DPC4, a candidate tumor suppressor gene at human
chromosome 18q21.1. Science. 271:350–353. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Le Clerc S, Limou S, Coulonges C,
Carpentier W, Dina C, Taing L, Delaneau O, Labib T, Sladek R,
Deveau C, et al: ANRS Genomic Group: Genomewide association study
of a rapid progression cohort identifies new susceptibility alleles
for AIDS (ANRS Genomewide Association Study 03). J Infect Dis.
200:1194–1201. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
46
|
Michaud-Levesque J and Richard S:
Thrombospondin-1 is a transcriptional repression target of PRMT6. J
Biol Chem. 284:21338–21346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jegga AG, Gowrisankar S, Chen J and Aronow
BJ: PolyDoms: A whole genome database for the identification of
non-synonymous coding SNPs with the potential to impact disease.
Nucleic Acids Res. 35(Database): D700–D706. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yue P and Moult J: Identification and
analysis of deleterious human SNPs. J Mol Biol. 356:1263–1274.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bonasio R, Lecona E and Reinberg D: MBT
domain proteins in development and disease. Semin Cell Dev Biol.
21:221–230. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ip WK, Lai PB, Wong NL, Sy SM, Beheshti B,
Squire JA and Wong N: Identification of PEG10 as a progression
related biomarker for hepatocellular carcinoma. Cancer Lett.
250:284–291. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen J, Zheng H, Bei JX, et al: Genetic
structure of the Han Chinese population revealed by genome-wide SNP
variation. Am J Hum Genet. 85:775–785. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wellcome Trust Case Control Consortium:
Genome-wide association study of 14,000 cases of seven common
diseases and 3,000 shared controls. Nature. 447:661–678. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Duggal P, Gillanders EM, Holmes TN and
Bailey-Wilson JE: Establishing an adjusted p-value threshold to
control the family-wide type 1 error in genome wide association
studies. BMC Genomics. 9:5162008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Teleman AA, Chen YW and Cohen SM:
Drosophila Melted modulates FOXO and TOR activity. Dev Cell.
9:271–281. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sjöblom T, Jones S, Wood LD, et al: The
consensus coding sequences of human breast and colorectal cancers.
Science. 314:268–274. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Jensen LJ, Kuhn M, Stark M, Chaffron S,
Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, et
al: STRING 8 - a global view on proteins and their functional
interactions in 630 organisms. Nucleic Acids Res. 37(Database):
D412–D416. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Matys V, Fricke E, Geffers R, Gössling E,
Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis
OV, et al: TRANSFAC: Transcriptional regulation, from patterns to
profiles. Nucleic Acids Res. 31:374–378. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Matsushima-Nishiwaki R, Shidoji Y,
Nishiwaki S, Yamada T, Moriwaki H and Muto Y: Aberrant metabolism
of retinoid X receptor proteins in human hepatocellular carcinoma.
Mol Cell Endocrinol. 121:179–190. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zender L, Villanueva A, Tovar V, Sia D,
Chiang DY and Llovet JM: Cancer gene discovery in hepatocellular
carcinoma. J Hepatol. 52:921–929. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
van Hengel J, D'Hooge P, Hooghe B, Wu X,
Libbrecht L, De Vos R, Quondamatteo F, Klempt M, Brakebusch C and
van Roy F: Continuous cell injury promotes hepatic tumorigenesis in
cdc42-deficient mouse liver. Gastroenterology. 134:781–792. 2008.
View Article : Google Scholar : PubMed/NCBI
|
